Prot #INCB-MA-MF-401: Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date6/12/186/12/21

Funding

  • Syneos Health, Inc. (Prot #INCB-MA-MF-401)
  • Incyte Corporation (Prot #INCB-MA-MF-401)